remission

AB1771-HPR COMPARISON OF FLARES IN 85 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, WHO DISCONTINUED, REDUCED DOSE OR MAINTAINED HYDROXYCHLOROQUINE DURING A PROSPECTIVE STUDY OF OPHTHALMOLOGICAL SCREENING FOR RETINOPATHY
J. Marques Dias, K. Chevalier, V. Vasseu, E. Laumonier, S. Derrien, N. Morel, V. Le Guern, A. Mathian, M. Mauget Faysse, Y. Nguyen, N. Costedoat

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 2120; DOI: 10.1136/annrheumdis-2023-eular.2774
AB1634 RISK FACTORS ASSOCIATED WITH PARCIAL OR NULL REMISSION OF RENAL ACTIVITY IN PATIENTS WITH LUPUS NEPHRITIS
A. Martínez Badajoz, J. R. Hernández Vásquez, M. Ocampo Torres, A. Ramirez Pérez, A. Camargo, F. M. Bravo Rojas, J. Hernandez Rivera

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 2051; DOI: 10.1136/annrheumdis-2023-eular.4113
AB1107 PSORIATIC ARTHRITIS: IMPROVEMENT IN OUTCOMES BUT PERSISTENT SEX DIFFERENCE - 5 YEAR FOLLOW UP STUDY OF A NORWEGIAN OUTPATIENT CLINIC POPULATION
K. Łosińska, B. Michelsen, A. Kavanaugh, M. Korkosz, G. Haugeberg

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1781-1782; DOI: 10.1136/annrheumdis-2023-eular.5371
AB1134 IMPACT OF INFLAMMATORY BOWEL DISEASE ON DAPSA REMISSION IN PATIENTS WITH PSORIATIC ARTHRITIS: A PROPENSITY SCORE-MATCHED RETROSPECTIVE ANALYSIS OF “CROSS” MULTIDISCIPLINARY PROJECT PATIENTS’.
M. Giannotta, V. Venerito, L. Pacello, M. B. Principi, C. Foti, A. Di Leo, F. Iannone

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1797-1798; DOI: 10.1136/annrheumdis-2023-eular.1829
AB1146 PHYSICIAN ADHERENCE TO CLINICAL GUIDELINES IN RHEUMATOLOGY: CAN IT HELP PROVIDING EVIDENCE-BASED, STANDARDIZED CLINICAL DECISIONS.
Y. El Miedany, N. Kamel, M. H. Abu-Zaid, A. Abdel-Nasser, M. A. Mortada, W. Hassan, S. A. Mahran, H. Sayed, R. Abdel Khalek, N. Fouad, S. A. A. Tabra, W. Elwakil, S. Saber

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1803; DOI: 10.1136/annrheumdis-2023-eular.1090
AB0965 EXTRA-AXIAL MANIFESTATIONS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: THE COURSE AND RESPONSE TO THERAPEUTIC AGENTS
A. Yilmaz, E. Bektaş, A. Canik, B. Artim-Esen, M. Inanc, A. Gül, Y. Yalçinkaya

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1701-1702; DOI: 10.1136/annrheumdis-2023-eular.5700
AB0785 ASSOCIATED FACTORS TO REMISSION IN PATIENTS WITH UVEITIS RELATED TO BEHÇET DISEASE TO THE FIRST THERAPEUTIC SCHEME
M. Cosentino, I. Gandino, C. Pena, M. C. Baretto, A. Testi, B. M. Virasoro, L. Garcia, M. Scolnik, A. Ringer, C. Siegrist, B. Abdala, S. Chulibert, M. Dalpiaz, G. Rodriguez, A. Schlaen, C. Vanegas, C. Alanez, M. Heredia, M. García

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1602-1603; DOI: 10.1136/annrheumdis-2023-eular.2112
AB0789 AVACOPAN IN THE REAL-LIFE PRACTICE: EVALUATION OF EFFICACY, SAFETY, AND IMPACT ON QUALITY OF LIFE IN THE EARLY STAGES OF TREATMENT
E. Treppo, F. Bello, E. Galli, R. Padoan, S. Monti, L. Moroni, E. Tombetti, S. Affatato, E. Conticini, B. Frediani, F. Alberici, L. Dagna, C. Montecucco, F. Schiavon, G. Emmi, C. Salvarani, L. Quartuccio

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1606; DOI: 10.1136/annrheumdis-2023-eular.4738
AB0703 TOWARDS TREAT-TO-TARGET PATIENT CENTRED CARE: DEVELOPMENT OF MULTIDIMENSIONAL DISEASE SPECIFIC PATIENT REPORTED OUTCOME MEASURES QUESTIONNAIRE FOR GIANT CELL ARTERITIS
Y. El Miedany, D. Palmer, M. Toth, M. Elgaafary, S. Bahlas, S. A. Mahran, M. H. Abu-Zaid, W. Hassan, W. Elwakil

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1555; DOI: 10.1136/annrheumdis-2023-eular.1107
AB0720 DEVELOPMENT OF RESPONSE CRITERIA FOR GCA: AN SLR INFORMING AN INTERNATIONAL TASK FORCE
C. Sanchez-Alvarez, M. Bond, M. Soowamber, D. Camellino, M. Anderson, C. Langford, C. Dejaco, Z. Touma, S. Ramiro

Annals of the Rheumatic Diseases Jun 2023, 82 (Suppl 1) 1565; DOI: 10.1136/annrheumdis-2023-eular.4165

Main menu

remission

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

remission

Pages